Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
266 results found
2024 ∙ Besteman, S. B. Bogaert, D. Bont, L. Mejias, A. Ramilo, O. Weinberger, D. M. Dagan, R.
Interactions between respiratory syncytial virus and Streptococcus pneumoniae in the pathogenesis of childhood respiratory infections: a systematic review
Newborn Children Adolescents Pneumococcal disease Efficacy/effectiveness
Rating:
Low
2024 ∙ Bardach, A. Ruvinsky, S. Palermo, M. C. Alconada, T. Sandoval, M. M. Brizuela, M. E. Wierzbicki, E. R. Cantos, J. Gagetti, P. Ciapponi, A.
Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis
Americas All age groups Pneumococcal disease Efficacy/effectiveness
Rating:
Low
2024 ∙ Papagiannis, D. Kourek, C. Briasoulis, A. Fradelos, E. C. Papagianni, E. D. Papadimopoulos, I. Giamouzis, G. Skoularigis, J. Xanthopoulos, A.
Pneumococcal and Influenza Vaccination Coverage in Patients with Heart Failure: A Systematic Review
All age groups Pneumococcal disease Influenza Coverage
Rating:
Not applicable
2024 ∙ Santangelo, O. E. Provenzano, S. Vella, C. Fermi, S. Facchini, L. Rizzo, M. Brighina, F. Cedrone, F. Firenze, A.
Safety and efficacy of vaccinations in patients with multiple sclerosis: a systematic review
All age groups COVID-19 Influenza Measles Mumps Rubella Yellow fever Varicella Tetanus Tick-borne encephalitis Diphtheria Pertussis Meningococcal disease Pneumococcal disease Rabies Haemophilus influenzae type B Hepatitis B Efficacy/effectiveness Safety Administration
Rating:
Critically low
2024 ∙ Du, P. Jin, S. Lu, S. Wang, L. Ma, X. Wang, J. Huang, R. Luo, Q. Yang, S. Feng, X.
Strategies to increase the coverage of influenza and pneumonia vaccination in older adults: a systematic review and network meta-analysis
Adults Older adults Influenza Pneumococcal disease Coverage
Rating:
Not applicable
2024 ∙ Price, O. Swanton, R. Grebely, J. Hajarizadeh, B. Webb, P. Peacock, A. Dore, G. J. Cowie, B. C. Vickerman, P. Degenhardt, L.
Vaccination coverage among people who inject drugs: A systematic review
All age groups COVID-19 Hepatitis A Hepatitis B Human papillomavirus (HPV) Influenza Pneumococcal disease Tetanus Coverage
Rating:
Not applicable
2024 ∙ Pereira, A. Pinho, C. Oliveira, A. Santos, R. Felgueiras, M. Martins, J. P.
Vaccination Promotion Strategies in the Elderly: Systematic Review and Meta-Analysis
Adults Older adults Influenza Pneumococcal disease COVID-19 Coverage
Rating:
Not applicable
2024 ∙ NACI
Recommendations on the use of pneumococcal vaccines in adults, including PNEU-C-21
Recommendation Americas Canada Adults Pneumococcal disease
Download:
2024 ∙ NIAC
Updated recommendations for pneumococcal conjugate vaccination in childhood in Ireland
Recommendation Europe Ireland Pneumococcal disease
Download:
2024 ∙ NACI
Economic Evidence Supplementary Appendix to the Recommendations for Public Health Programs on the Use of Pneumococcal Vaccines in Children, Including the Use of 15-Valent and 20-Valent Conjugate Vaccines
Background paper Americas Canada Pneumococcal disease
Download:
Loading...